Page 27 - FPGEE Management Q&A Book

www.pharmacyexam.com Krisman

perform for that patient. The protocol shall include, 3. Theophyllin.
but need not be limited to: 4. Levothyroxine.
5. Lithium carbonate.
(1). the specific drug or drugs to be managed by the 6. Digoxin.
pharmacist, 7. Warfarin sodium.

(2). the terms and conditions under which drug 22.(c) Attitude is the major barrier that prevents
therapy may be implemented, modified or pharmacists from communicating effectively with
discontinued, prescribers. There are a number of barriers that
prevent an effective communication between
(3). the conditions and events upon which the pharmacists and other healthcare professionals.
pharmacist is required to notify the physician, and Out of these, attitude, time, and knowledge are
major concerns.
(4). the laboratory tests that may be ordered. All
activities performed by the pharmacist in 1. Attitude
conjunction with the protocol shall be documented 2. Time and money
in the patient’s medical record. 3. Skill and knowledge

The pharmacist shall report at least every thirty 1. Attitude: The attitude is the most common
days to the physician regarding the patient’s drug barrier that prevents the effective communication
therapy management. between pharmacists and prescribers.

The collaborative drug therapy management The attitudes and expectations of pharmacists are
agreement and protocols shall be available for developed on the basis of previous experience. Due
inspection by the Departments of Public Health and to complex healthcare settings, pharmacists believe
Consumer Protection. A copy of the protocol shall that physicians are usually unapproachable, and
be filed in the patient’s medical record. therefore many pharmacists simply avoid
contacting the physician unless it is strictly
20.(b) The warning “Caution: Federal law prohibits necessary.
the transfer of this drug to any person other than
the patient for whom it was prescribed” is required One of the conferences in the UK reported that
for filling Schedule II, III and IV controlled drugs. “pharmacists see doctors as diagnosticians”
This cautionary label is not required when whereas physicians see themselves as a last
dispensing the Schedule V controlled substance or resource to provide health-related services to
dispensing the drug which is used for Double Blind patients, and physicians see pharmacists as
Study. medication dispensers, while pharmacists see
themselves as “drug experts.”
21.(b) I and II only. The FDA has acknowledged that
there are certain drugs in which small changes in 2. Time and money: Lack of time is an excuse
the dose and/or blood concentration may provided by pharmacists to avoid communication
potentially affect the drug’s pharmacological and with other healthcare professionals.
toxicological properties.
However, it is also true that many pharmacists who
These drugs are known as Narrow Therapeutic work in retail settings have no sufficient help to
Index (NTI) drugs. The list of such drugs is: provide extended health-related services to
patients.
1. Phenytoin.
2. Carbamazepine.

72